Clinical Trial Update: Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma [Phase 1]

View source ↗

Summary

This Phase 1 trial investigated fludarabine followed by adoptive immunotherapy in patients with stage IV melanoma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Fludarabine (Fludarabine)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED